11月 2025
- 首頁
- Mersana Therapeutics, Inc.
11月 2025Mersana Therapeutics, Inc.的市場佔有率分析
The development of ADCs is not a one-size-fits-all approach. In fact, a number of diverse factors impact the properties of an ADC, including payload, drug-to-antibody ratio, site of conjugation and homogeneity. For each target antigen, there is an optimal combination of these factors. Our novel and highly differentiated platforms have allowed us to optimize these properties […]
Mersana Therapeutics, Inc.(包含公司地區)
查看更多網站流量與參與度資訊- mersana.com
Mersana Therapeutics, Inc.截至 11月 2025 的總收入為 25M - 50M
Mersana Therapeutics, Inc. 熱門網域產生的總收入
Mersana Therapeutics, Inc. 熱門網域 3 年內的總收入
Mersana Therapeutics, Inc. 熱門網域的總收入
Mersana Therapeutics, Inc.的熱門網域總造訪量
了解Mersana Therapeutics, Inc.市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Mersana Therapeutics, Inc.的熱門網域平均造訪時長
分析Mersana Therapeutics, Inc.參與度指標。
過去 3 個月平均造訪時長
子公司細目
Mersana Therapeutics, Inc.的熱門網域平均頁面瀏覽量
了解Mersana Therapeutics, Inc.如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Mersana Therapeutics, Inc.
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Day One Biopharmaceuticals, Inc. is planning to acquire Mersana Therapeutics, Inc. for $285M.Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) has announced a definitive merger agreement to acquire Mersana Therapeutics in a deal valued at up to $285 million, marking a major expansion of its oncology portfolio.
11月 13, 2025閱讀更多
新聞Day One Biopharmaceuticals, Inc. is planning to acquire Mersana Therapeutics, Inc. for $285M.Day One Biopharmaceuticals moves to acquire Mersana Therapeutics in $285m cancer-drug deal.
11月 13, 2025閱讀更多
新聞Mersana Therapeutics, Inc. attends event ASCO 2025 Annual Meeting.Mersana Therapeutics announces upcoming Emi-Le oral and poster presentations at ASCO 2025 Annual Meeting.
4月 23, 2025閱讀更多
查看所有Mersana Therapeutics, Inc.信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。